Evidence map›Paper›PMID 36445578›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2023

Sampling of Human Microbiomes to Screen for Antibiotic-Producing Commensals.

Benjamin Torres Salazar, Anna Lange, Laura Camus, Simon Heilbronner

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Benjamin Torres SalazarInterfaculty Institute of Microbiology and Infection Medicine, Institute for Medical Microbiology and Hygiene, Tübingen, Germany.
Anna LangeInterfaculty Institute of Microbiology and Infection Medicine, Institute for Medical Microbiology and Hygiene, Tübingen, Germany.
Laura CamusInterfaculty Institute of Microbiology and Infection Medicine, Institute for Medical Microbiology and Hygiene, Tübingen, Germany.
Simon HeilbronnerInterfaculty Institute of Microbiology and Infection Medicine, Institute for Medical Microbiology and Hygiene, Tübingen, Germany. simon.heilbronner@uni-tuebingen.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Soil-derived microorganisms have been sampled intensively throughout the last decades in order to discover bacterial strains that produce new antibiotics. The increasing emergence of multidrug-resistant bacteria and the constant high demand for new antibiotic classes are leading to the sampling and investigation of new microbiomes that contain antimicrobial producers. Human-associated microbiomes are therefore gaining more and more attention. This chapter presents a detailed description of how human microbiomes can be sampled and how microbiota members from skin and nasal samples can be isolated. Different methods for antimicrobial compound screening are presented.

Indexed as

Anti-Bacterial AgentsMicrobiotaHumansNoseSkinSoilAnti-Bacterial AgentsSoilAntimicrobial compoundESKAPE pathogensIsolation of bacterial strainsMicrobiome samplingNoseSkinStaphylococcus

Identifiers

PMID36445578

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.